2017 annual financial data
TG Therapeutics 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was -61,532.32%.
Operating income was -118,711,751 USD and net income was -118,476,012 USD.
Operating cash flow was -93,763,562 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,381 USD
- Operating income
- -118,711,751 USD
- Net income
- -118,476,012 USD
- Operating cash flow
- -93,763,562 USD